Switch to:
GuruFocus has detected 1 Warning Sign with Valeant Pharmaceuticals International Inc $VRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cash Flow from Financing
$-1,963 Mil (TTM As of Dec. 2016)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2016, Valeant Pharmaceuticals International Inc paid $0 Mil more to buy back shares than it received from issuing new shares. It spent $519 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0 Mil from paying cash dividends to shareholders. It spent $56 Mil on other financial activities. In all, Valeant Pharmaceuticals International Inc spent $575 Mil on financial activities for the three months ended in Dec. 2016.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Valeant Pharmaceuticals International Inc's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

Cash from Financing(A: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=0+-1216+0+0+-747
=-1,963

Valeant Pharmaceuticals International Inc's Cash from Financing for the quarter that ended in Dec. 2016 is

Valeant Pharmaceuticals International Inc Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2016 was 259.2 (Mar. 2016 ) + -951.5 (Jun. 2016 ) + -696 (Sep. 2016 ) + -574.7 (Dec. 2016 ) = $-1,963 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Valeant Pharmaceuticals International Inc's net issuance of stock for the three months ended in Dec. 2016 was $0 Mil. Valeant Pharmaceuticals International Inc paid $0 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Valeant Pharmaceuticals International Inc's net issuance of debt for the three months ended in Dec. 2016 was $-519 Mil. Valeant Pharmaceuticals International Inc spent $519 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Valeant Pharmaceuticals International Inc's net issuance of preferred for the three months ended in Dec. 2016 was $0 Mil. Valeant Pharmaceuticals International Inc paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Valeant Pharmaceuticals International Inc's cash flow for dividends for the three months ended in Dec. 2016 was $0 Mil. Valeant Pharmaceuticals International Inc received $0 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Valeant Pharmaceuticals International Inc's other financing for the three months ended in Dec. 2016 was $-56 Mil. Valeant Pharmaceuticals International Inc spent $56 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Net Issuance of Stock 11-301-2-639-2812,25201,3610
Net Issuance of Debt -41803242012,7713,4752,012-2,26712,639-1,216
Net Issuance of Preferred 0000000000
Dividends -322-180-147-356000000
Other Financing -0-0-0-56-183-137-236-193-376-747
Cash from Financing -729-210177-2131,9483,0574,028-2,46013,624-1,963

Valeant Pharmaceuticals International Inc Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Net Issuance of Stock 001,434-500-230000
Net Issuance of Debt -1,075-1,04610,8921,551-29223794-847-645-519
Net Issuance of Preferred 0000000000
Dividends 0000000000
Other Financing -7-52-19-175-80-78-535-104-52-56
Cash from Financing -1,082-1,09912,3061,325-109123259-952-696-575
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK